Stay current with the latest news on Blood Cancer United research programs, FDA approvals, research grants and awards, the Therapy Acceleration Program, Beat AML and other clinical research programs, and more.
Ryvu Therapeutics receives Orphan Drug Designation from FDA
KRAKOW, Poland, March 28, 2020 – Ryvu Therapeutics (WSE: RVU), a clinical-stage biopharmaceutical company developing novel small molecule therapies th…
Affimed Announces FDA Granted Orphan Drug Designation
HEIDELBERG, Germany, April 1, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their inn…
